Searched over 200M research papers for "cvd articles"
10 papers analyzed
These studies suggest cardiovascular disease is a major global health issue influenced by factors such as type 2 diabetes, chronic venous disease, socioeconomic status, natural disasters, and mental health, with significant disparities in prevention and treatment adherence, especially in low- and middle-income countries.
20 papers analyzed
Cardiovascular disease (CVD) is a prevalent comorbidity in individuals with type 2 diabetes mellitus (T2DM). A systematic review of literature from 2007 to 2017 revealed that approximately 32.2% of adults with T2DM are affected by CVD. The study analyzed data from 57 articles encompassing 4,549,481 individuals with T2DM, highlighting that coronary heart disease and stroke are significant contributors to CVD-related mortality in this population.
The prevalence of CVD among T2DM patients varies by region, with Europe contributing the most studies (46%), followed by the Western Pacific/China (21%), and North America (13%). This regional data underscores the global burden of CVD in diabetic populations and the need for targeted interventions.
Chronic venous disease (CVD) affects a significant portion of the global population, with varying prevalence across different clinical stages. A systematic review identified that the prevalence of C2 disease (varicose veins) is highest in Western Europe and lowest in the Middle East and Africa. Common risk factors include female sex, increasing age, obesity, prolonged standing, positive family history, parity, and Caucasian ethnicity.
The review highlighted significant heterogeneity in the epidemiological studies, indicating the need for standardized methodologies to better characterize the global burden of chronic venous disease.
South Asian migrants to high-income nations exhibit a 1.5-2 times greater prevalence of coronary artery disease (CAD) compared to age- and sex-adjusted Europids. Key drivers of this increased burden include higher rates of abdominal obesity, type 2 diabetes mellitus, and dyslipidemia. Lifestyle changes post-immigration, such as sedentary behavior and dietary modifications, further exacerbate these risks.
Distinct cultural, innate, and acquired factors contribute to the unique CVD risk profile in South Asians. Novel biomarkers like leptin and adipokines may offer insights into cardiometabolic risk determinants in this population.
Natural disasters significantly increase the prevalence and management challenges of CVD. Factors such as lack of access to medication, destruction of infrastructure, and heightened physical and mental stress contribute to the exacerbation of CVD conditions like myocardial infarction, acute coronary syndrome, hypertension, and heart failure.
Effective management during disasters includes the rapid establishment of health clinics, ensuring access to medication, and implementing stress control measures. These strategies are crucial for mitigating the adverse effects of disasters on cardiovascular health.
Despite advances in prevention and treatment, CVD remains a leading cause of death and disability worldwide. Secondary prevention through pharmacologic interventions like aspirin, statins, and blood pressure-lowering agents has proven effective. However, there are significant gaps in the use of these therapies, particularly in low- and middle-income countries (LMICs), where adherence to medication is often poor.
Poor adherence to prescribed medications in chronic patients is directly correlated with higher incidences of recurrent cardiovascular events and increased healthcare costs. Addressing these barriers is essential for improving secondary prevention outcomes globally.
There is a well-documented socioeconomic skew in the prevalence and outcomes of CVD. A review of clinical trials and observational studies revealed that only 5% of studies reported on the socioeconomic status of participants, highlighting a significant gap in understanding how socioeconomic factors influence CVD outcomes.
The lack of consideration for socioeconomic differences in CVD research impairs the ability to assess the impact of new treatments on closing the inequality gap. More inclusive research is needed to address these disparities effectively.
Cardiovascular disease remains a major global health challenge, with significant variations in prevalence, risk factors, and outcomes across different populations and regions. Addressing these disparities through targeted interventions, improved management strategies, and inclusive research is crucial for reducing the global burden of CVD.
Most relevant research papers on this topic